8160 South Highland Drive
About Co-DiagnosticsCo-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our molecular diagnostics development platform is marketed under the brand name Co-Dx™. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide. YEAR FOUNDED:
Founder and CEO: Dwight (Ike) Egan
Founder and CTO: Brent Satterfield
Tweets by Co-Diagnostics
47 articles with Co-Diagnostics
Co-Diagnostics, Inc. announced that Dr. Eugene Durenard and Mr. Ted Murphy have joined the Board of Directors of Co-Diagnostics, and will serve on the Board’s Compensation and Corporate Governance/Nominating Committees and Audit Committees as independent directors.
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced the launch of their Logix Smart™ ZDC multiplex test at the 64th Annual 2019 Caribbean Public Health Agency Health Research Conference.
Co-Diagnostics, Inc. announced it has entered into two sales agreements for mosquito abatement laboratory equipment and mosquito tests, and expects additional sales agreements before the end of the quarter.
Co-Diagnostics, Inc. announced the filing of its operating results on SEC Form 10-Q for the 3 month period ending March 31, 2019 and provided updates on corporate developments.
Method includes proprietary, single-step closed-tube NGS library prep in 3 hours or less
CoSara Diagnostics facility to be among the first of its kind in India
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced the filing of their financial results for FY 2018, ending December 31, 2018, as well as updates on the Company’s growth and progress for 2018 in the following areas
Conference hosted at U.S. corporate headquarters to include training for distributors and end-users of Company’s diagnostic, research, and vector-control products
Logix Smart™ ZDC Test now available for export from the United States as a CE-marked IVD
Co-Diagnostics Completes Submission of CE Mark Registration for Zika/Dengue/Chikungunya Multiplex Test
Company’s multiplexed Logix Smart™ ZDC Test to be available for purchase with CE mark in March 2019
Co-Diagnostics, Inc. announced that it has received written notice from the Nasdaq Stock Market Listing Qualifications Staff on February 19, 2019, indicating that the Company has regained compliance with the minimum stockholders’ equity requirement as set forth in Nasdaq Capital Markets Listing Rule 5550.
Trainings will be conducted for staff and customers of Laboratorios Franja, including demonstrations of Company’s vector control products
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced the closing of its previously announced offering.
The closing of the offering is expected to occur on or about February 4, 2019, subject to the satisfaction of customary closing conditions.
Transaction included $3M of preferred shares, and the elimination of $2M of debt
Presentation coincided with launch of a private-label CoPrimer product
Company Senior Research Scientist will be a guest speaker of LGC, Biosearch
Co-Diagnostics CEO to Discuss Progress and Forecasts in a Lytham Partners’ Virtual Investors Conference Presentation on Tuesday, December 4, 2018 at 4:00 pm ET
Co-Diagnostics, Inc. announced today that it will discuss the Company’s recent progress and upcoming sales expectations on Tuesday, December 4, 2018 at 4:00 pm ET (3:00 pm CT) in a Lytham Partners’ Virtual Investors Conference Presentation.
Co-Diagnostics, Inc. to Conduct Product Training Seminars with Distributor and Customers in the Dominican Republic
Trainings will be conducted for staff and customers of Laboratorios Franja, followed by launch of Company’s products in DR
Co-Diagnostics agrees to license CoPrimers™ for use in agricultural applications